Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Elisaf

Showing results (111-120 of 248) with videos related to

Pageof 25
Sort By:
Metabolic Syndrome and Related Disorders|March 29, 2008
Increased serum ferritin concentrations and liver enzyme activities in patients with metabolic syndromeVasilis Tsimihodimos, Irene Gazi, Rigas Kalaitzidis, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 17, 2004
Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activityAfroditi P Tambaki, Evangelos Rizos, Vasilis Tsimihodimos, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 27, 2007
Statins and renal function. Is the compound and dose making a difference?Vasilios G Athyros, Asterios Karagiannis, Anna Kakafika, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 25, 2005
Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndromeEvangelos Rizos, Afroditi P Tambaki, Irene Gazi, et al.
World Journal of Clinical Cases|April 17, 2015
Dysbetalipoproteinemia: Two cases report and a diagnostic algorithmAnastazia Kei, George Miltiadous, Eleni Bairaktari, et al.
Pathology, Research and Practice|October 1, 2016
"Diabetic nephropathy" in a non-diabetic patientOlga Balafa, Georgios Liapis, Paraskevi Pavlakou, et al.
World Journal of Experimental Medicine|March 7, 2017
Statin escape phenomenon: Fact or fiction?Fotios Barkas, Moses Elisaf, Eleftherios Klouras, et al.
Pharmacogenetics and Genomics|May 3, 2005
Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemiaGeorge Miltiadous, Stavroulla Xenophontos, Eleni Bairaktari, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 13, 2007
Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinicGeorge Liamis, Vasilis Tsimihodimos, Michalis Doumas, et al.
Journal of the American Society of Hypertension : JASH|February 21, 2016
Does this patient have hypertensive encephalopathy?Foteini Christopoulou, Evangelos C Rizos, Paraskevi Kosta, et al.
Pageof 25

Showing results (111-120 of 248) with videos related to

Sort By:
Pageof 25
Metabolic Syndrome and Related Disorders|March 29, 2008
Increased serum ferritin concentrations and liver enzyme activities in patients with metabolic syndromeVasilis Tsimihodimos, Irene Gazi, Rigas Kalaitzidis, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 17, 2004
Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activityAfroditi P Tambaki, Evangelos Rizos, Vasilis Tsimihodimos, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 27, 2007
Statins and renal function. Is the compound and dose making a difference?Vasilios G Athyros, Asterios Karagiannis, Anna Kakafika, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 25, 2005
Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndromeEvangelos Rizos, Afroditi P Tambaki, Irene Gazi, et al.
World Journal of Clinical Cases|April 17, 2015
Dysbetalipoproteinemia: Two cases report and a diagnostic algorithmAnastazia Kei, George Miltiadous, Eleni Bairaktari, et al.
Pathology, Research and Practice|October 1, 2016
"Diabetic nephropathy" in a non-diabetic patientOlga Balafa, Georgios Liapis, Paraskevi Pavlakou, et al.
World Journal of Experimental Medicine|March 7, 2017
Statin escape phenomenon: Fact or fiction?Fotios Barkas, Moses Elisaf, Eleftherios Klouras, et al.
Pharmacogenetics and Genomics|May 3, 2005
Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemiaGeorge Miltiadous, Stavroulla Xenophontos, Eleni Bairaktari, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 13, 2007
Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinicGeorge Liamis, Vasilis Tsimihodimos, Michalis Doumas, et al.
Journal of the American Society of Hypertension : JASH|February 21, 2016
Does this patient have hypertensive encephalopathy?Foteini Christopoulou, Evangelos C Rizos, Paraskevi Kosta, et al.
Pageof 25